376 related articles for article (PubMed ID: 28506871)
1. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
2. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Tan G; Yu S; Pan H; Li J; Liu D; Yuan K; Yang X; Pan W
Int J Biol Macromol; 2017 Jan; 94(Pt A):355-363. PubMed ID: 27760378
[TBL] [Abstract][Full Text] [Related]
3. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo.
Zhang HH; Luo QH; Yang ZJ; Pan WS; Nie SF
Drug Deliv; 2011; 18(7):502-10. PubMed ID: 21790329
[TBL] [Abstract][Full Text] [Related]
4. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate.
Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W
Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
[TBL] [Abstract][Full Text] [Related]
7. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
9. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers.
Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT; Benítez-del-Castillo JM; García-Feijoo J; Herrero-Vanrell R
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3548-56. PubMed ID: 21296826
[TBL] [Abstract][Full Text] [Related]
11. Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol.
Nagai N; Ogata F; Otake H; Kawasaki N; Nakazawa Y; Kanai K; Okamoto N; Shimomura Y
Exp Eye Res; 2017 Dec; 165():118-124. PubMed ID: 28987318
[TBL] [Abstract][Full Text] [Related]
12. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
Shafaa MW; Sabra NM; Fouad RA
Biopharm Drug Dispos; 2011 Dec; 32(9):507-17. PubMed ID: 22028305
[TBL] [Abstract][Full Text] [Related]
13. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
Andreadis II; Karavasili C; Thomas A; Komnenou A; Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Mol Pharm; 2022 Jan; 19(1):274-286. PubMed ID: 34877863
[TBL] [Abstract][Full Text] [Related]
14. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic administration of a 10-fold-lower dose of conventional nanoliposome formulations caused levels of intraocular pressure similar to those induced by marketed eye drops.
Arroyo CM; Quinteros D; Cózar-Bernal MJ; Palma SD; Rabasco AM; González-Rodríguez ML
Eur J Pharm Sci; 2018 Jan; 111():186-194. PubMed ID: 28923571
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the ocular bioavailability of timolol by sorbic acid.
Higashiyama M; Inada K; Ohtori A; Tojo K
Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
18. Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study.
Zeng Y; Chen J; Li Y; Huang J; Huang Z; Huang Y; Pan X; Wu C
Life Sci; 2018 Nov; 212():80-86. PubMed ID: 30268857
[TBL] [Abstract][Full Text] [Related]
19. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
20. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
